Imatinib: a designer drug, another cutaneous complication

Authors: Dickens, E.¹; Lewis, F.²; Bienz, N.¹

Source: Clinical & Experimental Dermatology, Volume 34, Number 5, July 2009 , pp. 603-604(2)

Buy & download fulltext article:

Price: $48.00 plus tax (Refund Policy)

Abstract:

Summary

A 55-year-old man with a history of mild psoriasis was started on imatinib for chronic myeloid leukaemia. He developed new nail dystrophy after treatment with an exacerbation of his psoriasis. Although not a contraindication for this drug, it should be remembered that psoriasis may worsen with imatinib.

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-2230.2009.03250.x

Affiliations: 1: Departments of Haematology 2: Dermatology, Heatherwood and Wexham Park NHS Foundation Trust, Wexham Park Hospital, Slough, UK

Publication date: 2009-07-01